ARMISTICE CAPITAL LLC 13D/13G Filings for

ARMISTICE CAPITAL LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
1:36 pm
Purchase		2022-12-3113GTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC62,009
9.990%		29,841increase
(+92.76%)		Filing
2022-06-21
06:08 am
Unchanged		2022-06-2113GTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC1,608
9.990%		0
(Unchanged)		Filing
2022-06-17
5:16 pm
Purchase		2022-06-1013DTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC1,608
9.990%		0increase
(+0.02%)		Filing
2022-05-20
4:52 pm
Unchanged		2022-05-1713DTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC1,608
9.990%		0
(Unchanged)		Filing
2021-07-09
5:14 pm
Sale		2021-07-0613DTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC1,608
9.990%		-125decrease
(-7.23%)		Filing
2020-07-16
4:24 pm
Purchase		2020-07-0613DTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC1,733
19.990%		1,470increase
(+558.56%)		Filing
2020-03-23
5:03 pm
Purchase		2020-03-1113GTenax Therapeutics, Inc.
TENX		ARMISTICE CAPITAL LLC263
5.600%		263increase
(New Position)		Filing